anti-PD1 antibody-activated TILs

PD-1 antibody-activated tumor-infiltrating lymphocytes

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for anti-PD1 antibody-activated TILs, covering 2019-04-04 to 2019-04-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Combination of Anti-PD1 Antibody-activated TILs and Chemotherapy in Colorectal Cancer [Phase 1, Phase 2]

See pricing